Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

MDxHealth (MDXH) FCF Margin: 2021-2025

Historic FCF Margin for MDxHealth (MDXH) over the last 5 years, with Sep 2025 value amounting to 8.67%.

  • MDxHealth's FCF Margin rose 1655.00% to 8.67% in Q3 2025 from the same period last year, while for Sep 2025 it was 14.39%, marking a year-over-year increase of 1655.00%. This contributed to the annual value of 28.77% for FY2024, which is 1407.00% up from last year.
  • Per MDxHealth's latest filing, its FCF Margin stood at 8.67% for Q3 2025, which was down 48.66% from 5.83% recorded in Q2 2025.
  • MDxHealth's FCF Margin's 5-year high stood at 137.97% during Q2 2022, with a 5-year trough of 119.29% in Q1 2022.
  • Over the past 3 years, MDxHealth's median FCF Margin value was 25.23% (recorded in 2024), while the average stood at 23.00%.
  • As far as peak fluctuations go, MDxHealth's FCF Margin surged by 25,009bps in 2022, and later plummeted by 166bps in 2024.
  • MRQ analysis of 5 years shows MDxHealth's FCF Margin stood at 116.73% in 2021, then surged by 41bps to 69.41% in 2022, then soared by 53bps to 32.51% in 2023, then grew by 16bps to 27.45% in 2024, then soared by 68bps to 8.67% in 2025.
  • Its FCF Margin was 8.67% in Q3 2025, compared to 5.83% in Q2 2025 and 16.93% in Q1 2025.